Medical products company picks Charlotte area for its HQ, bringing 100 new jobs.
Safeguard Medical Acquires Made-in-America Splint Line
Safeguard Medical and PerSys Medical Announce Partnership Agreement
Safeguard Medical Announces New Partnership
Request a quote
The NIO Infant™ provides safe, rapid intraosseous access in the proximal tibia as an alternative to IV access in emergency medical situations.
When you need rapid IO access in infant patients, trust the NIO Infant™ to deliver safe, effective vascular access — no batteries, assembly, or extra parts required. Designed for patients from 2.3kg to 3 years of age, the NIO Infant™ features a 5mm marker line on its cannula, which confirms adequate needle length prior to insertion, while its unique Stepped Needle® delivers graduated penetration into the bone, helping to prevent over-penetration. Simple and safe-by-design, you can trust the NIO Infant™ to provide rapid infant IO access when every second counts.
NIO Infant: Introduction
NIO Infant IFU Video
Comparison of three intraosseous access devices for resuscitation of term neonates: a randomized simulation study
“…the first-attempt success rate for inserting the NIO™ in the tibia was 98%, Humerus 91%…”
NEW YORK INSTITUTE OF TECHNOLOGY COLLEGE OF OSTEOPATHIC MEDICINE
Safe on the bone2.
The NIO has proven to be safe on the bone and resulted in zero incidents of bone fracture as observed by post-insertion x-rays.
Easily tolerates common user errors3.
A recent study evaluated common user errors related to needle placement and found that even when placed up to 5cm from the correct insertion site, the NIO maintained an 85% success rate.
First attempt success rates as high as 98%1.
Initial studies demonstrated an overall average success rate of 91.3% for the proximal tibia and 93.1% for the humeral head. The New York Institute of Osteopathic Medicine conducted an additional study which established a proximal tibia success rate of over 98%1